O'SullivanJB, MahanCM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes, 1964; 13: 278–285.
2.
Hapo Study Cooperative ResearchGroup, MetzgerBE, LoweLP, et al.Hyperglycemia and adverse pregnancy outcomes. N Engl J Med, 2008; 358: 1991–2002.
3.
HillierTA, PedulaKL, OgasawaraKK, et al.A pragmatic, randomized clinical trial of gestational diabetes screening. N Engl J Med, 2021; 384: 895–904.
4.
DavisEM, AbebeKZ, SimhanHN, et al.Perinatal outcomes of two screening strategies for gestational diabetes mellitus: A randomized controlled trial. Obstet Gynecol, 2021; 138: 6–15.
5.
MurphyHR, HowgateC, O'KeefeJ, et al.Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: A 5-year national population-based cohort study. Lancet Diabetes Endocrinol, 2021; 9: 153–164.
6.
FeigDS, DonovanLE, ZinmanB, et al.Metformin in women with type 2 diabetes in pregnancy (MiTy): A multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol, 2020; 8: 834–844.
7.
TundidorD, MeekCL, YamamotoJ, et al.Continuous glucose monitoring time-in-range and HbA1c targets in pregnant women with type 1 diabetes. Diabetes Technol Ther, 2021; 23: 710–714
8.
O'MalleyG, OzaslanB, LevyCJ, et al.Longitudinal observation of insulin use and glucose sensor metrics in pregnant women with type 1 diabetes using continuous glucose monitors and insulin pumps: The LOIS-P Study. Diabetes Technol Ther, 2021; 23: 807–817
9.
WuytsC, SimoensC, PintoS, PhilippaertK, VennekensR. Continuous glucose monitoring during pregnancy in healthy mice. Sci Rep, 2021; 11: 4450.
10.
AsbjornsdottirB, VestgaardM, DoNC, et al.Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control. Diabet Med, 2021; 38: e14506.
11.
NørgaardSK, MathiesenER, NørgaardK, RingholmL. Comparison of glycemic metrics measured simultaneously by intermittently scanned continuous glucose monitoring and real-time continuous glucose monitoring in pregnant women with type 1 diabetes. Diabetes Technol Ther, 2021; 23: 665–672
12.
MeekCL, OramRA, McDonaldTJ, et al.Reappearance of C-peptide during the third trimester of pregnancy in type 1 diabetes: Pancreatic regeneration or fetal hyperinsulinism?. Diabetes Care, 2021; 44: 1826–1834.
13.
GrigsbyAB, AndersonRJ, FreedlandKE, ClouseRE, LustmanPJ. Prevalence of anxiety in adults with diabetes: A systematic review. J Psychosom Res, 2002; 53: 1053–1060.
14.
LustmanPJ, AndersonRJ, FreedlandKE, de GrootM, CarneyRM, ClouseRE. Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care, 2000; 23: 934–942.
15.
HaskovaA, RadovnickaL, PetruzelkovaL, et al.Real-time CGM is superior to flash glucose monitoring for glucose control in type 1 diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care, 2020; 43: 2744–2750.
